Previous Article | Next Article ![]()
Journal of Virology, June 2006, p. 6192-6194, Vol. 80, No. 12
0022-538X/06/$08.00+0 doi:10.1128/JVI.00526-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
You Lu,
Xun Sun,
Julie Johnston,
Roberto Calcedo,
Rebecca Grant, and
James M. Wilson*
Gene Therapy Program, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
Received 14 March 2006/ Accepted 20 March 2006
Adeno-associated virus (AAV) vectors are being considered for in vivo applications of gene therapy in the treatment of a variety of disorders. This study evaluates the biology of second-generation vectors based on the novel serotypes AAV7 and AAV8 and containing self-complementary genomes in the nonhuman primate liver. Stable levels of transgene expression were achieved in cynomolgus macaques and suggest efficiencies at least 2 log higher than what could be achieved with AAV2 vectors using traditional single-stranded genomes. Analysis of DNAs from tissues revealed high levels of vector in the liver that appeared proportional to the relative amounts of transgene expression.
These authors contributed equally to this work.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»